Advertisement
Advertisement
Trending on BioPharm International
1
Cellares Extends Cell Therapy Automation Beyond T Cell Therapies
2
Eisai Secures Exclusive Japan Commercial Rights to Henlius’ Anti-PD-1 Serplulimab
3
FDA Clears Affinia’s AFTX-201 for Phase I/II BAG3 Cardiomyopathy Trial
4
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
5
